United States (US) Type 2 Diabetes Market (2025-2031) | Companies, Growth, Industry, Competitive Landscape, Share, Value, Analysis, Trends, Outlook, Segmentation, Size & Revenue, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Type 2 Diabetes Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Type 2 Diabetes Market - Industry Life Cycle

3.4 United States (US) Type 2 Diabetes Market - Porter's Five Forces

3.5 United States (US) Type 2 Diabetes Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Type 2 Diabetes Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of obesity in the United States leading to a higher risk of developing type 2 diabetes

4.2.2 Growing geriatric population in the U.S. who are more susceptible to type 2 diabetes

4.2.3 Technological advancements in diabetes management and treatment options improving patient outcomes

4.3 Market Restraints

4.3.1 High healthcare costs associated with managing type 2 diabetes leading to financial burden on patients and healthcare systems

4.3.2 Lack of awareness about preventive measures and early detection of diabetes in the general population

4.3.3 Regulatory challenges impacting the introduction of new diabetes treatments and devices in the market

6.1 United States (US) Type 2 Diabetes Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Type 2 Diabetes Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Type 2 Diabetes Market Revenues & Volume, By Insulins, 2021- 2031F

6.1.4 United States (US) Type 2 Diabetes Market Revenues & Volume, By DPP-4 Inhibitors, 2021- 2031F

6.1.5 United States (US) Type 2 Diabetes Market Revenues & Volume, By GLP-1 Receptor Agonists, 2021- 2031F

6.1.6 United States (US) Type 2 Diabetes Market Revenues & Volume, By SGLT-2 Inhibitors, 2021- 2031F

6.2 United States (US) Type 2 Diabetes Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Type 2 Diabetes Market Revenues & Volume, By Drugstore, 2021- 2031F

6.2.3 United States (US) Type 2 Diabetes Market Revenues & Volume, By Hospital, 2021- 2031F

6.2.4 United States (US) Type 2 Diabetes Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Type 2 Diabetes Market Export to Major Countries

7.2 United States (US) Type 2 Diabetes Market Imports from Major Countries

8.1 Average HbA1c levels in the U.S. diabetic population

8.2 Adoption rate of digital health solutions for diabetes management

8.3 Number of new diabetes drugs or devices approved by regulatory authorities

8.4 Rate of hospitalizations due to diabetes-related complications

8.5 Percentage of type 2 diabetes patients achieving recommended treatment goals

9.1 United States (US) Type 2 Diabetes Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Type 2 Diabetes Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Type 2 Diabetes Market Revenue Share, By Companies, 2024

10.2 United States (US) Type 2 Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters